Alpiny

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

116 API Suppliers, 80 USDMF, 22 CEP/COS, 16 JDMF, 7 EU WC, 108 KDMF, 107 NDC API, 30 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

FINISHED DOSAGE FORMULATIONS

2528 FDF Dossiers, 729 FDA Orange Book, 503 Europe, 290 Canada, 75 Australia, 402 South Africa, 529 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUPPOSITORY;RECTAL - 120MG, SUPPOSITORY;RECTAL - 325MG, SUPPOSITORY;RECTAL - 650MG, SUPPOSITORY;RECTAL - 80MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 325MG;37.5MG, SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 325MG;5MG, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 1 Evonik, 14 Rochem International Inc, 31 SPI Pharma, 2 Seqens, 32 DKSH, 3 Jai Radhe Sales, 3 Pharm-RX Chemical, 14 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 18 Gangwal Healthcare, 22 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 19 Actylis, 3 Aeon Procare, 4 Alcedo Pharmachem, 13 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 44 BASF, 8 Beneo, 2 Bioplus Life Sciences, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 4 Finar, 17 Gangwal Chemicals, 2 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 27 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 13 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 56 Roquette, 22 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 4 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

146 Fillers, Diluents & Binders, 81 Thickeners and Stabilizers, 71 Solubilizers, 69 Coating Systems & Additives, 62 Direct Compression, 60 Taste Masking, 54 Topical, 50 Disintegrants & Superdisintegrants, 46 Parenteral, 40 Controlled & Modified Release, 40 Lubricants & Glidants, 40 Film Formers & Plasticizers, 40 Granulation, 27 Chewable & Orodispersible Aids, 26 Emulsifying Agents, 24 Co-Processed Excipients, 18 Rheology Modifiers, 15 Surfactant & Foaming Agents, 13 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

13 DATA COMPILATION #PharmaFlow, 339 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 406 Finished Drug Prices, 20 Annual Reports

MARKET PLACE

173 APIs, 95 FDF Dossiers

PATENTS & EXCLUSIVITIES

41 US Patents, 2 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 7 USP, 1 JP, 26 Others

ANALYTICAL

2 BioAnalytical Methods, 8 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20802 / DOSAGE - TABLET;ORAL - 250MG;250MG;65MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ACETAMINOPHEN(UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D)	ACETAMINOPHEN	250mg
ASPIRIN(UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E)	ASPIRIN	250mg
CAFFEINE(UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E)	CAFFEINE	65mg

Inactive Ingredients

Ingredient Name	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	Novartis Consumer Health, Inc.	7-Eleven	BJWC	Cardinal Health	DZA Brands LLC	HyVee Inc	Kmart Corporation	Kroger Company	L. Perrigo Company	REMEDYREPACK INC.	Shopko Stores Operating Co., LLC	Strategic Sourcing Services LLC	Target Corporation	Topco Associates LLC	Wakefern Food Corporation
ALUMINUM OXIDE(LMI26O6933)
BENZOIC ACID(8SKN0B0MIM)
CARNAUBA WAX(R12CBM0EIZ)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK)
CROSPOVIDONE(68401960MK)
CROSPOVIDONE, UNSPECIFIED(2S7830E561)
FD&C BLUE NO. 1(H3R47K3TBD)
HYDROXYPROPYL CELLULOSE(RFW2ET671P)
HYPROMELLOSE(3NXW29V3WO)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
LIGHT MINERAL OIL(N6K5787QVP)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYSORBATE 20(7T1F30V5YH)
POVIDONE(FZ989GH94E)
POVIDONE, UNSPECIFIED(FZ989GH94E)
POVIDONES(FZ989GH94E)
PROPYLENE GLYCOL(6DC9Q167V3)
SACCHARIN SODIUM(SB8ZUX40TY)
SORBITAN MONOLAURATE(6W9PS8B71J)
STARCH, CORN(O8232NY3SJ)
STEARIC ACID(4ELV7Z65AP)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Alpiny

Alpiny

Alpiny

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

116 API Suppliers

80 USDMF

22 CEP/COS

16 JDMF

7 EU WC

108 KDMF

107 NDC API

30 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

40 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

FINISHED DOSAGE FORMULATIONS

2528 FDF Dossiers

729 FDA Orange Book

503 Europe

290 Canada

75 Australia

402 South Africa

529 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUPPOSITORY;RECTAL - 120MG

SUPPOSITORY;RECTAL - 325MG

SUPPOSITORY;RECTAL - 650MG

SUPPOSITORY;RECTAL - 80MG

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG;250MG;65MG

TABLET;ORAL - 325MG;37.5MG

SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 300MG;15MG

TABLET;ORAL - 300MG;30MG

TABLET;ORAL - 300MG;60MG

TABLET;ORAL - 325MG;5MG

TABLET;ORAL - 325MG;50MG;40MG

TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

2 Minakem

1 Evonik

14 Rochem International Inc

31 SPI Pharma

2 Seqens

32 DKSH

3 Jai Radhe Sales

3 Pharm-RX Chemical

14 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

18 Gangwal Healthcare

22 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

19 Actylis

3 Aeon Procare

4 Alcedo Pharmachem

13 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

44 BASF

8 Beneo

2 Bioplus Life Sciences

6 Clariant

12 Corel Pharma Chem

7 DFE Pharma

4 Finar

17 Gangwal Chemicals

2 Huzhou Sunflower Pharmaceutical

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons